Biblio

Export 239 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
E. L. Boespflug, Simon, M. J., Leonard, E., Grafe, M., Woltjer, R., Silbert, L. C., Kaye, J. A., and Iliff, J. J., Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease., J Alzheimers Dis, vol. 66, no. 4, pp. 1587-1597, 2018.
A. Boehm-Cagan, Bar, R., Liraz, O., Bielicki, J. K., Johansson, J. O., and Michaelson, D. M., ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies., J Alzheimers Dis, vol. 54, no. 3, pp. 1219-1233, 2016.
M. Bocchetta, Mega, A., Bernardi, L., Di Maria, E., Benussi, L., Binetti, G., Borroni, B., Colao, R., Di Fede, G., Fostinelli, S., Galimberti, D., Gennarelli, M., Ghidoni, R., Piaceri, I., Pievani, M., Porteri, C., Redaelli, V., Rossi, G., Suardi, S., Babiloni, C., Scarpini, E., Tagliavini, F., Padovani, A., Nacmias, B., Sorbi, S., Frisoni, G. B., and Bruni, A. C., Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol., J Alzheimers Dis, vol. 51, no. 1, pp. 277-91, 2016.
M. Bocchetta, Iglesias, J. Eugenio, Scelsi, M. A., Cash, D. M., M Cardoso, J., Modat, M., Altmann, A., Ourselin, S., Warren, J. D., and Rohrer, J. D., Hippocampal Subfield Volumetry: Differential Pattern of Atrophy in Different Forms of Genetic Frontotemporal Dementia., J Alzheimers Dis, vol. 64, no. 2, pp. 497-504, 2018.
V. Boccardi, Ruggiero, C., Patriti, A., and Marano, L., Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 4, pp. 947-55, 2016.
V. Boccardi, Staffa, M. Conestabil, Baroni, M., Ercolani, S., Croce, M. Francesco, Ruggiero, C., and Mecocci, P., Prevalence and Correlates of Behavioral Disorders in Old Age Subjects with Cognitive Impairment: Results from the ReGAl Project., J Alzheimers Dis, vol. 60, no. 4, pp. 1275-1283, 2017.
V. Boccardi, Baroni, M., Smirne, N., Clodomiro, A., Ercolani, S., Longo, A., Ruggiero, C., Bruni, A. C., and Mecocci, P., Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study., J Alzheimers Dis, vol. 56, no. 1, pp. 239-248, 2017.
N. Bobkova, Vorobyov, V., Medvinskaya, N., Nesterova, I., Tatarnikova, O., Nekrasov, P., Samokhin, A., Deev, A., Sengpiel, F., Koroev, D., and Volpina, O., Immunization Against Specific Fragments of Neurotrophin p75 Receptor Protects Forebrain Cholinergic Neurons in the Olfactory Bulbectomized Mice., J Alzheimers Dis, vol. 53, no. 1, pp. 289-301, 2016.
M. Boada, Santos-Santos, M. A., Rodríguez-Gómez, O., Alegret, M., Cañabate, P., Lafuente, A., Abdelnour, C., Buendia, M., de Dios, M. José, Morera, A., Sanabria, Á., Campo, L., Ruiz, A., and Tárraga, L., Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research., J Alzheimers Dis, vol. 62, no. 3, pp. 1079-1090, 2018.
M. Boada, Anaya, F., Ortiz, P., Olazarán, J., Shua-Haim, J. R., Obisesan, T. O., Hernandez, I., Muñoz, J., Buendia, M., Alegret, M., Lafuente, A., Tárraga, L., Núñez, L., Torres, M., Grifols, J. Ramon, Ferrer, I., Lopez, O. L., and Páez, A., Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial., J Alzheimers Dis, vol. 56, no. 1, pp. 129-143, 2017.
J. Krzysztof Blusztajn, Aytan, N., Rajendiran, T., Mellott, T. J., Soni, T., Burant, C. F., Serrano, G. E., Beach, T. G., Lin, H., and Stein, T. D., Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease., J Alzheimers Dis, vol. 95, no. 4, pp. 1623-1634, 2023.
E. R. Blonz, Alzheimer's Disease as the Product of a Progressive Energy Deficiency Syndrome in the Central Nervous System: The Neuroenergetic Hypothesis., J Alzheimers Dis, vol. 60, no. 4, pp. 1223-1229, 2017.
V. Bloniecki, Aarsland, D., Blennow, K., Cummings, J., Falahati, F., Winblad, B., and Freund-Levi, Y., Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid., J Alzheimers Dis, vol. 57, no. 2, pp. 387-393, 2017.
I. Blockx, Einstein, S., Guns, P. - J., Van Audekerke, J., Guglielmetti, C., Zago, W., Roose, D., Verhoye, M., Van der Linden, A., and Bard, F., Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model., J Alzheimers Dis, vol. 54, no. 2, pp. 723-35, 2016.
K. Bloch, Gil-Ad, I., Vanichkin, A., Hornfeld, S. Henry, Koroukhov, N., Taler, M., Vardi, P., and Weizman, A., Intracerebroventricular Streptozotocin Induces Obesity and Dementia in Lewis Rats., J Alzheimers Dis, vol. 60, no. 1, pp. 121-136, 2017.
K. Bloch, Gil-Ad, I., Vanichkin, A., Hornfeld, S. Henry, Taler, M., Dar, S., Azarov, D., Vardi, P., and Weizman, A., Intracranial Transplantation of Pancreatic Islets Attenuates Cognitive and Peripheral Metabolic Dysfunctions in a Rat Model of Sporadic Alzheimer's Disease., J Alzheimers Dis, vol. 65, no. 4, pp. 1445-1458, 2018.
K. Blennow and Zetterberg, H., The Past and the Future of Alzheimer's Disease Fluid Biomarkers., J Alzheimers Dis, vol. 62, no. 3, pp. 1125-1140, 2018.
J. Blautzik, Kotz, S., Brendel, M., Sauerbeck, J., Vettermann, F., Winter, Y., Bartenstein, P., Ishii, K., and Rominger, A., Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment., J Alzheimers Dis, vol. 65, no. 3, pp. 781-791, 2018.
C. M. Black, Fillit, H., Xie, L., Hu, X., M Kariburyo, F., Ambegaonkar, B. M., Baser, O., Yuce, H., and Khandker, R. K., Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 185-193, 2018.
M. Bjerke, Kern, S., Blennow, K., Zetterberg, H., Waern, M., Börjesson-Hanson, A., Östling, S., Kern, J., and Skoog, I., Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years., J Alzheimers Dis, vol. 49, no. 3, pp. 733-41, 2016.
M. Bjerke and Engelborghs, S., Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis., J Alzheimers Dis, vol. 62, no. 3, pp. 1199-1209, 2018.
A. Bittar, Al-Lahham, R., Bhatt, N., Moore, K., Montalbano, M., Jerez, C., Fung, L., McAllen, S., Ellsworth, A., and Kayed, R., Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner., J Alzheimers Dis, vol. 90, no. 3, pp. 1103-1122, 2022.
R. Biswas, Kawas, C., Montine, T. J., Bukhari, S. A., Jiang, L., and Corrada, M. M., Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study., J Alzheimers Dis, vol. 93, no. 2, pp. 561-575., 2023.
M. Bisbe, Fuente-Vidal, A., López, E., Moreno, M., Naya, M., de Benetti, C., Milà, R., Bruna, O., Boada, M., and Alegret, M., Comparative Cognitive Effects of Choreographed Exercise and Multimodal Physical Therapy in Older Adults with Amnestic Mild Cognitive Impairment: Randomized Clinical Trial., J Alzheimers Dis, vol. 73, no. 2, pp. 769-783, 2020.
C. Birkenbihl, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., and Hofmann-Apitius, M., ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset., J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.

Pages